Histiocyte Society blueprint for non-Langerhans cell histiocytosis research: unraveling complex diseases through collaboration. [PDF]
Hershkovitz-Rokah O +3 more
europepmc +1 more source
Application of pretreatment <sup>18</sup>F-FDG PET metabolic parameters in children with Langerhans cell histiocytosis. [PDF]
Wen X +7 more
europepmc +1 more source
Low Bone Mass in Probable CD1a-negative Langerhans Cell Histiocytosis: A Diagnostic Challenge. [PDF]
Masri R +4 more
europepmc +1 more source
Patients with langerhans cell histiocytosis and hypothalamic-pituitary involvement: insights from the HEROS study cohort. [PDF]
Masri Iraqi H +12 more
europepmc +1 more source
Langerhans Cell Histiocytosis and Other Histiocytic Lesions. [PDF]
McKinney RA, Wang G.
europepmc +1 more source
A rare case of Langerhans cell histiocytosis with unexplained endocrine dysfunction and extensive skeletal involvement in a Pediatric patient. [PDF]
Díaz Q C +4 more
europepmc +1 more source
Sustained Response to Pan-BRAF Inhibitor Plixorafenib (FORE8394, PLX8394) in a Young Adult With Neurodegenerative Langerhans Cell Histiocytosis. [PDF]
Yi JS +11 more
europepmc +1 more source
TERT Promoter C228T and C250T Hotspot Mutations Are Absent in BRAF V600E-Positive Langerhans Cell Histiocytosis. [PDF]
Silva AMD +3 more
europepmc +1 more source
A rash not to miss: Langerhans cell histiocytosis. [PDF]
Cormier F, Sibbald C.
europepmc +1 more source

